Bank of Nova Scotia bought a new position in shares of Corteva, Inc. (NYSE:CTVA - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 71,961 shares of the company's stock, valued at approximately $6,095,000.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CTVA. Compass Financial Management LLC acquired a new stake in Corteva during the second quarter worth about $25,000. JPL Wealth Management LLC acquired a new stake in shares of Corteva during the 3rd quarter worth approximately $25,000. Garton & Associates Financial Advisors LLC purchased a new position in shares of Corteva during the 4th quarter valued at approximately $27,000. Bank of Jackson Hole Trust acquired a new position in shares of Corteva in the 4th quarter valued at $28,000. Finally, Cornerstone Financial Management LLC purchased a new stake in Corteva during the fourth quarter worth $29,000. 81.54% of the stock is currently owned by institutional investors and hedge funds.
Corteva Stock Up 0.4%
CTVA opened at $83.18 on Wednesday. The company has a market cap of $55.50 billion, a PE ratio of 55.09, a price-to-earnings-growth ratio of 2.54 and a beta of 0.57. Corteva, Inc. has a twelve month low of $60.53 and a twelve month high of $90.97. The company has a 50-day moving average price of $82.39 and a 200 day moving average price of $80.37. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07.
Corteva (NYSE:CTVA - Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The company had revenue of $6.38 billion for the quarter, compared to analysts' expectations of $6.60 billion. During the same period in the previous year, the firm posted $2.20 EPS. Corteva's revenue was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Sell-side analysts expect that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.
Corteva Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be paid a $0.18 dividend. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva's payout ratio is currently 47.68%.
Analyst Upgrades and Downgrades
A number of research analysts have weighed in on CTVA shares. Rothschild & Co Redburn upped their price objective on shares of Corteva from $80.00 to $90.00 and gave the stock a "neutral" rating in a research report on Wednesday, April 29th. Citigroup raised their target price on Corteva from $85.00 to $86.00 and gave the company a "neutral" rating in a research report on Monday, August 3rd. Mizuho lifted their price target on Corteva from $96.00 to $97.00 and gave the company an "outperform" rating in a research note on Tuesday, July 14th. Jefferies Financial Group upped their price target on Corteva from $95.00 to $97.00 in a report on Thursday, May 7th. Finally, Bank of America increased their price target on Corteva from $90.00 to $96.00 and gave the stock a "buy" rating in a research report on Monday, July 20th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $91.50.
Get Our Latest Stock Analysis on CTVA
About Corteva
(
Free Report)
Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Featured Articles
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Corteva, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.
While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
